{"filing":{"accession_number":"0001213900-26-075938","cik":"0001631487","ticker":"CLGN","company_name":"CollPlant Biotechnologies Ltd","form":"6-K","filing_date":"2026-07-07","report_date":null,"primary_document":"ea0297248-6k_collplant.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1631487/000121390026075938/ea0297248-6k_collplant.htm"},"events":[{"id":16409,"run_id":14662,"accession_number":"0001213900-26-075938","anchor_item_number":"EX-99.1","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.88,"summary":"CollPlant is holding an extraordinary general meeting of shareholders on July 29, 2026, to approve an increase in authorized share capital from 30 million to 500 million ordinary shares and amend the Memorandum and Articles of Association. The 16.7x increase in authorized shares is material to shareholders' interests and is intended to facilitate a private placement completed in June 2026 and provide flexibility for potential strategic transactions and acquisitions.","company_name":"CollPlant Biotechnologies Ltd","ticker":"CLGN","filing_date":"2026-07-07","form":"6-K","submitted_at":null,"items":[{"id":14500,"accession_number":"0001213900-26-075938","item_number":"EX-99.1","item_title":"ea029724801ex99-1.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"This exhibit is a notice and proxy statement for an extraordinary general meeting of shareholders scheduled for July 29, 2026, to approve an increase in authorized share capital from 30 million to 500 million ordinary shares and amend the Memorandum and Articles of Association accordingly. While the increase itself is governance-related (a bylaw/charter amendment requiring shareholder approval), the materiality derives from the stated purpose: to facilitate a private placement completed in June 2026 and to provide flexibility for potential strategic transactions and acquisitions. The 16.7x increase in authorized shares is material to shareholders' interests, though the specific event is a shareholder vote on a governance matter rather than a discrete operational or financial event.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-07T20:06:54.848086+00:00","company_name":"","ticker":null,"filing_date":""},{"id":14501,"accession_number":"0001213900-26-075938","item_number":"EX-99.2","item_title":"ea029724801ex99-2.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This exhibit is a proxy card and notice for an extraordinary general meeting scheduled for July 29, 2026, at which shareholders will vote on a resolution to increase the Company's authorized share capital from 30 million to 500 million ordinary shares and amend the Articles of Association accordingly. This is a governance matter involving shareholder authorization of a material capital structure change, though the proxy card itself is an administrative document rather than disclosure of voting results. The substantial increase in authorized shares (16.7x) is material to investors as it affects potential dilution and the company's capital-raising capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-07T20:06:54.848086+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14500,"accession_number":"0001213900-26-075938","item_number":"EX-99.1","item_title":"ea029724801ex99-1.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"This exhibit is a notice and proxy statement for an extraordinary general meeting of shareholders scheduled for July 29, 2026, to approve an increase in authorized share capital from 30 million to 500 million ordinary shares and amend the Memorandum and Articles of Association accordingly. While the increase itself is governance-related (a bylaw/charter amendment requiring shareholder approval), the materiality derives from the stated purpose: to facilitate a private placement completed in June 2026 and to provide flexibility for potential strategic transactions and acquisitions. The 16.7x increase in authorized shares is material to shareholders' interests, though the specific event is a shareholder vote on a governance matter rather than a discrete operational or financial event.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-07T20:06:54.848086+00:00","company_name":"CollPlant Biotechnologies Ltd","ticker":"CLGN","filing_date":"2026-07-07"},{"id":14501,"accession_number":"0001213900-26-075938","item_number":"EX-99.2","item_title":"ea029724801ex99-2.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This exhibit is a proxy card and notice for an extraordinary general meeting scheduled for July 29, 2026, at which shareholders will vote on a resolution to increase the Company's authorized share capital from 30 million to 500 million ordinary shares and amend the Articles of Association accordingly. This is a governance matter involving shareholder authorization of a material capital structure change, though the proxy card itself is an administrative document rather than disclosure of voting results. The substantial increase in authorized shares (16.7x) is material to investors as it affects potential dilution and the company's capital-raising capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-07T20:06:54.848086+00:00","company_name":"CollPlant Biotechnologies Ltd","ticker":"CLGN","filing_date":"2026-07-07"}]}